Intra-host competition between nef-defective escape mutants and wild-type human immunodeficiency virus type 1

被引:9
作者
Altes, HK [1 ]
Jansen, VAA [1 ]
机构
[1] Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Dept Zool, Oxford OX1 3PS, England
关键词
HIV-1; competition; mathematical model; nef; defective escape; live attenuated vaccine;
D O I
10.1098/rspb.2000.0985
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Various forms of nef genes with deletions at conserved positions along the sequence have been reported to persist in human immunodeficiency virus type 1 infected patients. We investigate the forces maintaining such variants in the proviral population. The main selection pressures are preservation of function and host immune response. The crippled Nef protein might have fewer epitopes, and as such be less visible to the specific immune response, but it will lose some function. Does a trade-off between avoidance of the immune response and loss of function explain the dynamics of the crippled virus found in the patients' To answer this question, we formulated a deterministic model of the virus-host interactions. We found that when the crippled protein presents few epitopes and suffers little loss of function, the two viral types can coexist. Otherwise, the wild-type comes to prevail. The mutant form might initially dominate, but as the selective pressure by the CD8+ T cells decreases over the course of infection, the advantage for the crippled form of losing epitopes disappears. Hence, we go from a situation of coexistence of wild-type and mutant, to a situation of only full-length nef. The results are discussed in the context of the suggested use of live attenuated vaccines having deletions in nef.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 70 条
[1]  
ANDERSON R M, 1991
[2]   Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques [J].
Baba, TW ;
Liska, V ;
Khimani, AH ;
Ray, NB ;
Dailey, PJ ;
Penninck, D ;
Bronson, R ;
Greene, MF ;
McClure, HM ;
Martin, LN ;
Ruprecht, RM .
NATURE MEDICINE, 1999, 5 (02) :194-203
[3]   PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J].
BABA, TW ;
JEONG, YS ;
PENNINCK, D ;
BRONSON, R ;
GREENE, MF ;
RUPRECHT, RM .
SCIENCE, 1995, 267 (5205) :1820-1825
[4]   HIV-1 NEF LEADS TO INHIBITION OR ACTIVATION OF T-CELLS DEPENDING ON ITS INTRACELLULAR-LOCALIZATION [J].
BAUR, AS ;
SAWAI, ET ;
DAZIN, P ;
FANTL, WJ ;
CHENGMAYER, C ;
PETERLIN, BM .
IMMUNITY, 1994, 1 (05) :373-384
[5]   Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains [J].
Berkhout, B ;
Verhoef, K ;
van Wamel, JLB ;
Back, NKT .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1138-1145
[6]   DEFECTIVE ESCAPE MUTANTS OF HIV [J].
BERRY, RM ;
NOWAK, MA .
JOURNAL OF THEORETICAL BIOLOGY, 1994, 171 (04) :387-395
[7]   CAN LIVE ATTENUATED VIRUS WORK AS POSTEXPOSURE TREATMENT [J].
BONHOEFFER, S ;
NOWAK, MA .
IMMUNOLOGY TODAY, 1995, 16 (03) :131-135
[8]   Who is right? Or, how to judge the disagreement about HLA restriction of Nef peptides - Comment [J].
Brander, C ;
Walker, BD ;
Korber, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (11) :923-924
[9]  
BRANDER C, 1998, SYSTEMATIC IDENTIFIC
[10]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197